MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
660.80%
Quick Ratio
660.80%
Cash Ratio
466.01%
Debt to Asset Ratio
43.70%
Unit: Thousand (K) dollars
Assets Breakdown
    • Included within cash and cash eq...
    • Intangible assets, net
    • Goodwill
    • Others
Liabilities Breakdown
    • Common shares, no par value, 450...
    • Accumulated deficit
    • Warrant liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Included within cash and cash equivalents
37,355
35,939
40,791
40,463
Marketable securities
13,474
17,442
14,990
23
Accounts receivable
790
806
891
127
Prepaid expenses and other current assets
1,351
1,977
2,485
1,647
Total current assets
52,970
56,164
59,157
42,260
Property and equipment, net
2,517
2,497
2,566
2,157
Operating lease right-of-use assets
1,964
2,127
2,131
2,311
Deposits and other long-term assets
598
573
558
539
Goodwill
10,672
10,672
10,672
10,672
Intangible assets, net
31,700
31,700
31,700
31,700
Deferred tax asset, net
5,799
5,800
5,800
-
Total assets
106,220
109,533
112,584
89,639
Accounts payable and accrued liabilities
5,387
5,567
7,181
4,550
Operating lease liabilities, current portion
918
833
816
1,023
Finance lease liabilities, current portion
33
32
37
43
Deferred revenues, current portion
1,678
1,716
3,333
3,766
Total current liabilities
8,016
8,148
11,367
9,382
Deferred tax liability, net
22
22
22
273
Deferred revenues, net of current portion
12,339
12,999
12,377
12,462
Operating lease liabilities, net of current portion
1,333
1,507
1,534
1,515
Finance lease liabilities, net of current portion
15
22
32
40
Warrant liabilities
24,697
34,140
43,906
45,171
Total liabilities
46,422
56,838
69,238
68,843
Common shares, no par value, 450,000 shares authorized as of june 30, 2026 and december 31, 2025 252,907 and 243,122 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
535,717
529,656
515,467
494,175
Accumulated other comprehensive loss
-4,473
-3,971
-3,920
-4,286
Accumulated deficit
-470,328
-471,810
-466,998
-467,849
Lineage's shareholders' equity
60,916
53,875
44,549
22,040
Noncontrolling deficit
-1,118
-1,180
-1,203
-1,244
Total shareholders equity
59,798
52,695
43,346
20,796
Total liabilities and shareholders equity
106,220
109,533
112,584
89,639
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Included within cash andcash equivalents$37,355K (-11.63%↓ Y/Y)Marketable securities$13,474K (79158.82%↑ Y/Y)Prepaid expenses andother current assets$1,351K (3.92%↑ Y/Y)Accounts receivable$790K (208.59%↑ Y/Y)Total current assets$52,970K (20.81%↑ Y/Y)Intangible assets, net$31,700K (0.00%↑ Y/Y)Goodwill$10,672K (0.00%↑ Y/Y)Deferred tax asset, net$5,799K Property and equipment,net$2,517K (11.62%↑ Y/Y)Operating leaseright-of-use assets$1,964K (8.09%↑ Y/Y)Deposits and otherlong-term assets$598K (17.03%↑ Y/Y)Total assets$106,220K (16.98%↑ Y/Y)Total liabilities andshareholders equity$106,220K (16.98%↑ Y/Y)Total shareholdersequity$59,798K (26.93%↑ Y/Y)Total liabilities$46,422K (6.26%↑ Y/Y)Noncontrolling deficit-$1,118K (12.18%↑ Y/Y)Lineage's shareholders'equity$60,916K (25.90%↑ Y/Y)Warrant liabilities$24,697K (31.36%↑ Y/Y)Deferred revenues, net ofcurrent portion$12,339K (-3.23%↓ Y/Y)Total currentliabilities$8,016K (-25.47%↓ Y/Y)Operating leaseliabilities, net of current...$1,333K (25.99%↑ Y/Y)Deferred tax liability,net$22K (-91.94%↓ Y/Y)Finance leaseliabilities, net of current...$15K (-68.75%↓ Y/Y)Accumulated deficit-$470,328K (-7.36%↓ Y/Y)Accumulated othercomprehensive loss-$4,473K (-9.15%↓ Y/Y)Common shares, no parvalue, 450,000 shares...$535,717K (9.21%↑ Y/Y)Accounts payable andaccrued liabilities$5,387K (21.03%↑ Y/Y)Deferred revenues,current portion$1,678K (-68.08%↓ Y/Y)Operating leaseliabilities, current portion$918K (-8.02%↓ Y/Y)Finance leaseliabilities, current portion$33K (-34.00%↓ Y/Y)

Lineage Cell Therapeutics, Inc. (LCTX)

Lineage Cell Therapeutics, Inc. (LCTX)